jueves, 5 de marzo de 2020

Cancer Information Highlights, March 4, 2020

Cancer Information Highlights, March 4, 2020

National Cancer Institute



Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
New CAR T-Cell Therapy Reduces Side Effects in First Clinical Trial
chimeric antigen recepter structure Learn more about a new CAR T-cell therapy that causes fewer side effects in the brain and central nervous system but works as well as an earlier version of the treatment.
Study Finds No Disparities in Prostate Cancer Deaths with Equal Access to Care
older African American veteran with nurse Read about a study of men with prostate cancer treated in the Veterans Affairs health care system, where patients have equal access to care.
Mouse Study Points to Approach that May Preserve Bone during Chemotherapy

A new study in mice suggests that a process known as cellular senescence, which can be brought on by cancer treatments, may play a role in treatment-related bone loss. Senescence occurs when a cell stops dividing but does not die.
New Approach Uses Much Less Tissue to Analyze Tumor Proteins and Genes

Researchers have found a new way to use tissue from a core needle biopsy to study the proteins and genetic changes of a tumor. The information learned about the tumor may may help guide treatment.
PDQ Cancer Information Summary Updates
Skin Cancer Treatment

We’ve revised our PDQ summaries on skin cancer treatment with new staging images for melanoma and basal cell carcinoma and squamous cell carcinoma of the skin.
Treatment of Cancers of the Abdomen in Children and Teens

We’ve created summaries for each of the cancers covered in our PDQ summary on treatment for unusual cancers of childhood. This list highlights the treatment summaries for childhood cancers of the abdomen:

Unusual Cancers of Childhood Treatment will be removed from the website on April 17, 2020. See the full list of childhood cancer summaries.
Drug Information Updates
New Treatment for Bladder Cancer

We’ve added a new drug summary for enfortumab vedotin-ejfv (Padcev). The Food and Drug Administration (FDA) recently approved it to treat certain adults with locally advanced or metastatic urothelial carcinoma, which is a type of bladder cancer.
 
Also of Interest
HPV and Cancer

HPV infection can cause oral, cervical, anal, and other cancers. Learn what HPV is, how it spreads, symptoms it may cause, and who should get the HPV vaccine.
Rare Cancers

As a group, rare cancers make up just over a quarter of all cancers. Learn about the challenges that people with rare cancers, their doctors, and scientists face in making progress against these cancers.

No hay comentarios:

Publicar un comentario